A Daily Network publication
Explore the network
ETF Daily
The Definitive Daily Read on Exchange-Traded Funds
Monday, October 12, 2026The Morning Brief →Sign in
Active

T. Rowe Price's TMED makes the case for active sector ETFs

A 44-basis-point fee and a bottom-up, global mandate are beating the S&P health-care benchmark by wide margins.

At a glance

15-second brief
  • A 44-basis-point fee and a bottom-up, global mandate are beating the S&P health-care benchmark by wide margins.

  • TMED, the T. Rowe Price Health Care ETF, is an argument for active management inside a sector fund.

  • TMED's process is deliberately broad.

TMED, the T. Rowe Price Health Care ETF, is an argument for active management inside a sector fund. The fund charges 44 basis points and holds between 100 and 150 health-care stocks from around the world. It has returned about 19% so far this year. Its 12-month return is 49.1%, according to ETF Database data. The S&P Health Care Select Sector Index is up 8% year to date. Over the same 12 months, the index has gained 28.2%, T. Rowe Price says. ETF Trends reported the comparison.

TMED's process is deliberately broad. A bottom-up approach blends growth and value analysis across pharmaceuticals, biotech, and health-care services. Most of the fund sits inside the MSCI GICS health-care sector. The ETF wrapper adds transparency, flexibility, and tax efficiency — the same qualities that made sector funds a default vehicle. But the active remit separates this fund from the passive crowd. Many passive sector ETFs hold small, specialized indexes that can be volatile; broader passive baskets absorb the swings of the whole group. A manager with a mandate to range across the sector can skip the weakest companies and follow the strongest ideas where they lead.

TMED is becoming a useful test case for active sector ETFs. Its performance suggests a manager working company by company can beat the sector index without tying the fund to a narrow theme. The fund also arrives as active strategies gather momentum. ETF Daily's coverage has tracked $272.5 billion in active stock-fund inflows this year. Goldman Sachs has agreed to acquire NEOS, the $30 billion options-income issuer. In a portfolio, these funds are best treated as satellites, not cores — a way to express a sector view while handing stock selection to a manager.

Competitors face a process problem, not a packaging problem. Any issuer can put a health-care label on an active wrapper. The hard part is the research conviction that lets a manager range across a broad sector and still beat the index. TMED's numbers offer a template — and a target.

TMED vs. S&P Health Care Index Returns
TMED 12-mo49.1%
Index 12-mo28.2%
TMED YTD19%
Index YTD8%
ETF DATABASE DATA VIA ETF TRENDS; T. ROWE PRICE
TMED vs. S&P Health Care Index Returns
TMED 12-mo49.1%
Index 12-mo28.2%
TMED YTD19%
Index YTD8%
ETF DATABASE DATA VIA ETF TRENDS; T. ROWE PRICE
TMED vs. S&P Health Care Index Returns
TMED 12-mo49.1%
Index 12-mo28.2%
TMED YTD19%
Index YTD8%
ETF DATABASE DATA VIA ETF TRENDS; T. ROWE PRICE
Continue your research

Save this analysis and keep the funds you follow together in My Desk.

TMED · T. Rowe Price Health Care ETF →
Sign in to save articles or follow funds.
Sources & further reading
ETF Trends · ETF Daily
More from ETF Daily
Active

T. Rowe Price launches first European active ETFs with zero first-year fees

The Irish UCITS platform opens with two equity strategies, registering on Xetra on 8 October 2026, London on 15 October and Borsa Italiana on 22 October.
Active

ProShares files for AI hyperscaler bond ETF tracking VettaFi index

The index is nearly 75% AA-rated or higher, with almost half its holdings maturing in a decade or more.
The Tape

Infrastructure Capital launches SPYC, an active S&P 500 option-income ETF for Europe

Founder Jay Hatfield told ETF Express the firm manages roughly $4 billion, and SPYC joins NUKZ and PFFI in the lineup.
Elsewhere in the networkAll titles →
Every weekday · 6:30 a.m. ET

The Morning Brief

ETF launches, fund research, and market coverage in your inbox every weekday. Free.